Therefore, inhibition of the HIPK2/JNK/c-Jun signaling pathway has specific guiding significance for treating neonatal brain neurotoxicity and cognitive impairment, and it can be used as a potential target to treat general anesthetic-induced neurotoxicity and cognitive impairment. This evidence concerns the gene JUN and Cognitive impairment.